569.SI Vicplas International Ltd (SES) 11 Mar 2026: earnings due 12 Mar, S$0.09 valuation test

Earnings for Vicplas International Ltd (569.SI) are due 12 Mar 2026 and the market is watching a S$0.09 share price as the near-term reference. The 569.SI stock trades on the SES in Singapore with a current price of S$0.09 and low intraday volatility on 11 Mar 2026. With volume at 15,400 shares and a 50-day average of 0.09214, the earnings release is likely to drive short-term moves for this small-cap healthcare and piping group.

569.SI stock: earnings timeline and what traders should expect

Vicplas files earnings on 12 Mar 2026 and the market is pricing limited upside into the print. The stock opened at S$0.09 on 11 Mar 2026 with a day range of S$0.09–S$0.09 and average daily volume near 48,703, implying muted liquidity and wider spreads for big orders.

Earnings drivers and consensus points to watch

Key drivers include medical-device margins and pipes & fittings contract flow in Singapore, Malaysia and the UK. Analysts will watch revenue per share of 0.24 and the company’s recent revenue growth of 17.99% year-on-year to gauge operating momentum.

569.SI earnings: balance sheet, cash flow and valuation cues

Vicplas shows a market cap of S$45,996,903.00 and book value per share of 0.14. The price-to-book is 0.64 and price-to-sales is 0.38, which reflects a low valuation versus peers. The company reports net income per share of -0.00 (negative) and a negative free cash flow per share of -0.01, flagging profitability and cash generation risks ahead of the report.

Technicals and trading picture for 569.SI stock

Momentum indicators are subdued: RSI is 40.56 and the stock sits below its 50-day average of 0.09214. On 11 Mar 2026 volume was 15,400, below the average daily volume of 48,703, increasing the chance of larger price swings when earnings hit. Traders should expect thin liquidity and use limit orders where possible.

Meyka AI grade and model forecast for 569.SI

Meyka AI rates 569.SI with a score out of 100. Score: 63.47/100, Grade: B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of 0.09 and a 12-month projection of 0.087, implying an approximate -3.33% downside versus the current S$0.09 price. Forecasts are model-based projections and not guarantees.

Risks and opportunities for investors in 569.SI stock

Upside catalysts include contract wins in the medical-device division and margin improvement that could push a reasonable price target to S$0.12. Key risks are thin liquidity, ongoing negative net income per share, and long receivables cycles that weigh on cash conversion. A conservative downside scenario targets S$0.06 if earnings disappoint.

Final Thoughts

Vicplas International Ltd (569.SI) enters the 12 Mar 2026 earnings window with a current SES price of S$0.09, low intraday volume of 15,400, and mixed fundamentals. The company posts a low P/S of 0.38 and price-to-book of 0.64, but negative net income per share and weak free cash flow pose downside risk. Meyka AI’s model projects a 12-month level of 0.087, equating to roughly -3.33% from today’s price, while an optimistic price target of S$0.12 implies upside of about 33.33%. Given current liquidity and mixed metrics, the Meyka grade is B (HOLD) and investors should treat the earnings release as a catalyst for short-term volatility rather than a clear buy signal. Always factor in thin trading, Singapore SES execution costs in SGD, and that forecasts are model-based projections and not guarantees. Meyka AI provides this earnings spotlight as AI-powered market analysis to help frame risk and reward ahead of the report.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.